SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-14-040941
Filing Date
2014-02-07
Accepted
2014-02-07 17:06:27
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 d621316d424b4.htm 424B4 2325257
2 GRAPHIC g621316argos_logo001.jpg GRAPHIC 18595
3 GRAPHIC g621316g05i34.jpg GRAPHIC 54465
4 GRAPHIC g621316g11s18.jpg GRAPHIC 34580
5 GRAPHIC g621316g12q55.jpg GRAPHIC 21826
6 GRAPHIC g621316g18g71.jpg GRAPHIC 12218
7 GRAPHIC g621316g20v72.jpg GRAPHIC 46699
8 GRAPHIC g621316g29b04.jpg GRAPHIC 21680
9 GRAPHIC g621316g40c80.jpg GRAPHIC 48216
10 GRAPHIC g621316g74r12.jpg GRAPHIC 36305
11 GRAPHIC g621316g75f60.jpg GRAPHIC 22368
12 GRAPHIC g621316g84e76.jpg GRAPHIC 30754
13 GRAPHIC g621316g93t90.jpg GRAPHIC 31331
14 GRAPHIC g621316g98b63.jpg GRAPHIC 32562
15 GRAPHIC g621316g99r66.jpg GRAPHIC 38335
  Complete submission text file 0001193125-14-040941.txt   2948306
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-193137 | Film No.: 14585217
SIC: 2834 Pharmaceutical Preparations